These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 1661719

  • 21. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
    Leskinen H, Vuolteenaho O, Toth M, Ruskoaho H.
    Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
    [Abstract] [Full Text] [Related]

  • 22. Blockade of the response to volume expansion by monoclonal antibodies against atrial natriuretic peptides.
    Hirth C, Stasch JP, Kazda S, John A, Morich F, Neuser D, Wohlfeil S.
    Klin Wochenschr; 1987 May; 65 Suppl 8():87-91. PubMed ID: 2955164
    [Abstract] [Full Text] [Related]

  • 23. Neutral endopeptidase 24.11 inhibition reduces pulmonary vascular remodeling in rats exposed to chronic hypoxia.
    Winter RJ, Zhao L, Krausz T, Hughes JM.
    Am Rev Respir Dis; 1991 Dec; 144(6):1342-6. PubMed ID: 1835825
    [Abstract] [Full Text] [Related]

  • 24. Changes in ANP responsiveness of normal and hypertensive porcine intrapulmonary arteries during maturation.
    Matsushita T, Hislop AA, Boels PJ, Deutsch J, Haworth SG.
    Pediatr Res; 1999 Oct; 46(4):411-8. PubMed ID: 10509361
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of hypoxic pulmonary vasoconstriction in isolated rat resistance arteries by atrial natriuretic peptide.
    Rogers TK, Thompson JS, Morice AH.
    Eur Respir J; 1997 Sep; 10(9):2061-5. PubMed ID: 9311503
    [Abstract] [Full Text] [Related]

  • 26. Oxygen-mediated pulmonary vasodilation and plasma levels of endothelin-1, atrial natriuretic peptide and cyclic GMP in patients with left-to-right shunt and pulmonary hypertension.
    Gorenflo M, Bettendorf M, Ulmer HE, Brockmeier K.
    Z Kardiol; 2000 Feb; 89(2):100-8. PubMed ID: 10768278
    [Abstract] [Full Text] [Related]

  • 27. Suppression of the natriuretic effects of exogenous atrial natriuretic peptide in animals with total artificial hearts.
    Mabuchi K, Hayakawa H, Hirata Y, Iizuka M, Imachi K, Chinzei T, Nozawa H, Abe Y, Yonezawa T, Suzukawa M.
    ASAIO Trans; 1991 Feb; 37(3):M214-6. PubMed ID: 1661120
    [Abstract] [Full Text] [Related]

  • 28. Atrial natriuretic peptide in acute hypoxia-exposed healthy subjects and in hypoxaemic patients.
    Lordick F, Hauck RW, Senekowitsch R, Emslander HP.
    Eur Respir J; 1995 Feb; 8(2):216-21. PubMed ID: 7758554
    [Abstract] [Full Text] [Related]

  • 29. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
    Pesonen A, Leppäluoto J, Ruskoaho H.
    J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
    [Abstract] [Full Text] [Related]

  • 30. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat.
    Oparil S, Chen SJ, Meng QC, Elton TS, Yano M, Chen YF.
    Am J Physiol; 1995 Jan; 268(1 Pt 1):L95-100. PubMed ID: 7840234
    [Abstract] [Full Text] [Related]

  • 31. Endogenous nitric oxide production and atrial natriuretic peptide biological activity in infants undergoing cardiac operations.
    Seghaye MC, Duchateau J, Bruniaux J, Demontoux S, Détruit H, Bosson C, Lecronier G, Mokhfi E, Serraf A, Planché C.
    Crit Care Med; 1997 Jun; 25(6):1063-70. PubMed ID: 9201062
    [Abstract] [Full Text] [Related]

  • 32. Atrial natriuretic peptide-dependent modulation of hypoxia-induced pulmonary vascular remodeling.
    Chen YF, Feng JA, Li P, Xing D, Ambalavanan N, Oparil S.
    Life Sci; 2006 Aug 29; 79(14):1357-65. PubMed ID: 16714036
    [Abstract] [Full Text] [Related]

  • 33. Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans.
    Cargill RI, Lipworth BJ.
    Br J Clin Pharmacol; 1995 Dec 29; 40(6):585-90. PubMed ID: 8703666
    [Abstract] [Full Text] [Related]

  • 34. Preexisting cardiopulmonary disease attenuating the atrial natriuretic peptide response. Results in patients with acute respiratory failure.
    Westendorp RG, Roos AN, Walma ST, Frölich M, Meinders AE.
    Chest; 1992 Dec 29; 102(6):1758-63. PubMed ID: 1332838
    [Abstract] [Full Text] [Related]

  • 35. Brain natriuretic peptide: possible role in the modulation of hypoxic pulmonary hypertension.
    Hill NS, Klinger JR, Warburton RR, Pietras L, Wrenn DS.
    Am J Physiol; 1994 Mar 29; 266(3 Pt 1):L308-15. PubMed ID: 8166300
    [Abstract] [Full Text] [Related]

  • 36. Concomitant increase in plasma atrial natriuretic peptide and cyclic GMP during volume loading.
    Weil J, Lang RE, Suttmann H, Rampf U, Bidlingmaier F, Gerzer R.
    Klin Wochenschr; 1985 Dec 16; 63(24):1265-8. PubMed ID: 3003451
    [Abstract] [Full Text] [Related]

  • 37. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ, Espiner EA, Nicholls MG, Richards AM, Yandle TG.
    J Clin Endocrinol Metab; 1996 Nov 16; 81(11):3871-6. PubMed ID: 8923831
    [Abstract] [Full Text] [Related]

  • 38. Chronic infusion of atrial natriuretic peptide prevents pulmonary hypertension in hypoxia-adapted rats.
    Jin HK, Yang RH, Chen YF, Jackson RM, Oparil S.
    Trans Assoc Am Physicians; 1988 Nov 16; 101():185-92. PubMed ID: 2978635
    [No Abstract] [Full Text] [Related]

  • 39. Atrial natriuretic peptide in primary pulmonary hypertension.
    Morice AH, Pepke-Zaba J, Brown MJ, Thomas PS, Higenbottam TW.
    Eur Respir J; 1990 Sep 16; 3(8):910-3. PubMed ID: 2149841
    [Abstract] [Full Text] [Related]

  • 40. Protective effects of vasonatrin peptide against hypobaric hypoxia-induced pulmonary hypertension in rats.
    Yu J, Feng HS, Chen BY, Qu P, Liu LB, Chen JK, Tie R, Huang XJ, Zhao YF, Zhu XX, Zhu MZ.
    Clin Exp Pharmacol Physiol; 2010 Jan 16; 37(1):69-74. PubMed ID: 19566831
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.